Home » Clinical Trials » Leukemia » NCT04599543
NCT04599543

Clinical Trial for the Safety and Efficacy of IL3 CAR-T Cell Therapy for Patients With CD123 Positive Relapsed and/or Refractory Acute Myeloid Leukemia

Study Summary

A Study of IL3 CAR-T Cell Therapy for Patients With CD123 Positive Relapsed and/or Refractory Acute Myeloid Leukemia.

Want to learn more about this trial?

Request More Info

Interventions

IL3 CAR T-cellsDRUG
Each subject receive IL3 CAR T-cells by intravenous infusion

Study Locations

FacilityCityStateCountry
The First Affiliated Hospital，College of Medicine, Zhejiang UniversityHangzhouZhejiangChina

Official Trial Information

View on ClinicalTrials.gov

Data sourced from ClinicalTrials.gov. Last updated: April 14, 2026